Researchers from the department of anesthesiology at Tufts Medical Center in Boston looked at whether or not low doses of solubilized injectable diclofenac sodium would be effective for management of acute pain after abdominal or pelvic surgery, according to Anesthesia-Analgesia.
The researchers observed 331 patients who received small doses of the study drug or a placebo. No treatment-related serious adverse effects were reported in either diclofenac dose group, whereas only one was reported in the kerorolac group.
For patients with acute moderate and severe pain after abdominal or pelvic surgery, repeated lower doses of solubilized diclofenac provided significant analgesic efficacy, as compared with the placebo. It significantly reduced the need for opioids.
More Articles on Anesthesia:
Can ASCs Still Profit From Anesthesia? A Review of OIG Guidance
Anesthesiologist Dr. Brian Waltmann Joins MedNet as Medical Director
Regional Anesthesia May Reduce Blood Transfusions for Bilateral Knee Replacements
The researchers observed 331 patients who received small doses of the study drug or a placebo. No treatment-related serious adverse effects were reported in either diclofenac dose group, whereas only one was reported in the kerorolac group.
For patients with acute moderate and severe pain after abdominal or pelvic surgery, repeated lower doses of solubilized diclofenac provided significant analgesic efficacy, as compared with the placebo. It significantly reduced the need for opioids.
More Articles on Anesthesia:
Can ASCs Still Profit From Anesthesia? A Review of OIG Guidance
Anesthesiologist Dr. Brian Waltmann Joins MedNet as Medical Director
Regional Anesthesia May Reduce Blood Transfusions for Bilateral Knee Replacements